Non-invasive brain stimulation approaches to fibromyalgia pain

Journal of Pain Management

Volumn 2, Issue 3, 2009, Pages 259-275

  Short, E Baron ^a   Borckardt, Jeffrey J ^a   George, Mark ^a   Beam, Will ^a   Reeves, Scott T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Chronic pain; Electroconvulsive therapy; Fibromyalgia; Noninvasive brain stimulation; Prefrontal cortex; Primary motor cortex; Transcranial direct current stimulation; Transcranial magnetic stimulation

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; MILNACIPRAN; NORADRENALIN; PAROXETINE; SEROTONIN; STEROID;

AEROBIC EXERCISE; BECK DEPRESSION INVENTORY; BRAIN BLOOD FLOW; BRAIN DEPTH STIMULATION; CAUDATE NUCLEUS; DEPRESSION; ELECTROCONVULSIVE THERAPY; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FATIGUE; FIBROMYALGIA; GENETIC ASSOCIATION; HEALTH CARE COST; HEALTH STATUS; HUMAN; HYPERSENSITIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KINESIOTHERAPY; LOW DRUG DOSE; MENTAL STRESS; MORBIDITY; MOTOR CORTEX; NONHUMAN; PAIN THRESHOLD; PROTEIN EXPRESSION; PSYCHOTHERAPY; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SLEEP DISORDER; STEROID THERAPY; STRESS; THALAMUS; TRANSCRANIAL MAGNETIC STIMULATION; VISUAL ANALOG SCALE;

EID: 77955836289     PISSN: 19395914     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (161)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33(2):160-72.
2. Bradley LA. Pathophysiologic mechanisms of fibromyalgia and its related disorders. J Clin Psychiatry 2008;69 Suppl 2:6-13.
3. Ledeboer A, Hutchinson MR, Watkins LR, Johnson KW. Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin Investig Drugs 2007;16(7):935-50.
4. Watkins LR, Milligan ED, Maier SF. Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol 2003;521:1-21.
5. Arnold LM, Hudson JI, Hess EV, Ware AE, Fritz DA, Auchenbach MB, et al. Family study of fibromyalgia. Arthritis Rheum 2004; 50(3):944-52.
6. Bradley L FR, Sotolongo A, et al. Family aggregation of pain sensitivity in fibromyalgia. J Pain 2006;7(4):S1.
7. Wolfe F, Russell IJ, Vipraio G, Ross K, Anderson J. Serotonin levels, pain threshold, and fibromyalgia symptoms in the general population. J Rheumatol 1997;24(3):555-9. (Pubitemid 27153424)
8. Offenbaecher M, Bondy B, de Jonge S, Glatzeder K, Kruger M, Schoeps P, et al. Possible association of fibromyalgia with a polymorphism in the serotonin transporter gene regulatory region. Arthritis Rheum 1999;42(11):2482-8. (Pubitemid 30333429)
9. Cohen H, Buskila D, Neumann L, Ebstein RP. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 2002;46(3):845-7. (Pubitemid 34214272)
10. Hoefgen B, Schulze TG, Ohlraun S, von Widdern O, Hofels S, Gross M, et al. The power of sample size and homogenous sampling: association between the 5-HTTLPR serotonin transporter polymorphism and major depressive disorder. Biol Psychiatry 2005; 57(3):247-51.
11. Yeo A, Boyd P, Lumsden S, Saunders T, Handley A, Stubbins M, et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004; 53(10):1452-8.
12. Park JM, Choi MG, Park JA, Oh JH, Cho YK, Lee IS, et al. Serotonin transporter gene polymorphism and irritable bowel syndrome. Neurogastroenterol Motil 2006;18(11):995-1000. (Pubitemid 44571651)
13. Aaron LA, Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. Best Pract Res Clin Rheumatol 2003;17(4):563-74. (Pubitemid 36869129)
14. Al-Allaf AW, Dunbar KL, Hallum NS, Nosratzadeh B, Templeton KD, Pullar T. A case-control study examining the role of physical trauma in the onset of fibromyalgia syndrome. Rheumatology (Oxford) 2002;41(4):450-3.
15. Demitrack MA, Crofford LJ. Evidence for and pathophysiologic implications of hypothalamic-pituitary-adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann N Y Acad Sci 1998;840:684-97.
16. Harkness EF, Macfarlane GJ, Nahit E, Silman AJ, McBeth J. Mechanical injury and psychosocial factors in the work place predict the onset of widespread body pain: a two-year prospective study among cohorts of newly employed workers. Arthritis Rheum 2004;50(5):1655-64. (Pubitemid 38608089)
17. Davis MC, Zautra AJ, Reich JW. Vulnerability to stress among women in chronic pain from fibromyalgia and osteoarthritis. Ann Behav Med 2001;23(3):215-26.
18. Okonkwo R BL, Sotolongo A, et al. Effect of stressful imagery on thermal pain ratings of patients with fibromyalgia: what mediates this relationship? J Pain 2007;8(4):S25.
19. McCain GA, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol Suppl 1989;19:154-7.
20. Crofford LJ, Pillemer SR, Kalogeras KT, Cash JM, Michelson D, Kling MA, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994;37(11):1583-92. (Pubitemid 24345804)
21. Bou-Holaigah I, Calkins H, Flynn JA, Tunin C, Chang HC, Kan JS, et al. Provocation of hypotension and pain during upright tilt table testing in adults with fibromyalgia. Clin Exp Rheumatol 1997; 15(3):239-46. (Pubitemid 27261941)
22. Martínez-Lavín M HA, Rosas M, et al. Circadian studies of autonomic nervous balance in patients with fibromyalgia: a heart rate variability analysis. Arthritis Rheum 1998;41:1966-71. (Pubitemid 28506686)
23. Martinez-Lavin M, Hermosillo AG, Mendoza C, Ortiz R, Cajigas JC, Pineda C, et al. Orthostatic sympathetic derangement in subjects with fibromyalgia. J Rheumatol 1997;24(4):714-8. (Pubitemid 27146090)
24. Vaeroy H, Qiao ZG, Morkrid L, Forre O. Altered sympathetic nervous system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 1989;16(11):1460-5. (Pubitemid 20015360)
25. Roizenblatt S, Moldofsky H, Benedito-Silva AA, Tufik S. Alpha sleep characteristics in fibromyalgia. Arthritis Rheum 2001; 44(1):222-30.
26. Harding SM. Sleep in fibromyalgia patients: subjective and objective findings. Am J Med Sci 1998;315(6):367-76.
27. Russell IJ, Vaeroy H, Javors M, Nyberg F. Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992;35(5):550-6.
28. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC. Plasma tryptophan and other amino acids in primary fibromyalgia: a controlled study. J Rheumatol 1992;19(1):90-4.
29. Schwarz MJ, Spath M, Muller-Bardorff H, Pongratz DE, Bondy B, Ackenheil M. Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients. Neurosci Lett 1999;259(3):196-8. (Pubitemid 29059617)
30. Sicuteri F. Headache as possible expression of deficiency of brain 5-hydroxytryptamine (central denervation supersensitivity). Headache 1972;12(2):69-72.
31. Fishbain D. Evidence-based data on pain relief with antidepressants. Ann Med 2000;32(5):305-16. (Pubitemid 30496575)
32. Wood PB, Patterson JC, 2nd, Sunderland JJ, Tainter KH, Glabus MF, Lilien DL. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: a pilot study. J Pain 2007;8(1):51-8.
33. Wood PB, Holman AJ. An elephant among us: the role of dopamine in the pathophysiology of fibromyalgia. J Rheumatol 2009; 36(2):221-4.
34. Gur A, Oktayoglu P. Status of immune mediators in fibromyalgia. Curr Pain Headache Rep 2008;12(3):175-81.
35. Maier SF. Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition. Brain Behav Immun 2003;17(2):69-85.
36. Watkins LR, Maier SF. The pain of being sick: implications of immune-to-brain communication for understanding pain. Annu Rev Psychol 2000;51:29-57.
37. Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 2003;35(1):2-11. (Pubitemid 36356868)
38. Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci 2002;966:343-54.
39. Wallace DJ. Is there a role for cytokine based therapies in fibromyalgia. Curr Pharm Des 2006;12(1):17-22.
40. Roberts K, Papadaki A, Goncalves C, Tighe M, Atherton D, Shenoy R, et al. Contact heat evoked potentials using simultaneous EEG and fMRI and their correlation with evoked pain. BMC Anesthesiol 2008;8(8):8.
41. Kwiatek R, Barnden L, Tedman R, Jarrett R, Chew J, Rowe C, et al. Regional cerebral blood flow in fibromyalgia: single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum 2000;43(12):2823-33. (Pubitemid 32001750)
42. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002;46(5):1333-43. (Pubitemid 34525843)
43. Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 2004; 50(2):613-23. (Pubitemid 38198845)
44. Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, et al. Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 1995;38(7):926-38.
45. Gracely E. The role of quasi-experimental designs in pain research. Pain Med 2004;5(2):146-7. (Pubitemid 39029245)
46. Giesecke T, Gracely RH, Williams DA, Geisser ME, Petzke FW, Clauw DJ. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum 2005; 52(5):1577-84. (Pubitemid 40663950)
47. Neumann L, Buskila D. Epidemiology of fibromyalgia. Curr Pain Headache Rep 2003;7(5):362-8.
48. Weir PT, Harlan GA, Nkoy FL, Jones SS, Hegmann KT, Gren LH, et al. The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th Revision codes. J Clin Rheumatol 2006;12(3):124-8.
49. Crofford LJ. Pharmaceutical treatment options for fibromyalgia. Curr Rheumatol Rep 2004;6(4):274-80.
50. Hajjar ER, Hanlon JT, Artz MB, Lindblad CI, Pieper CF, Sloane RJ, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr Pharmacother 2003;1(2):82-9.
51. Arnold LM, Rosen A, Pritchett YL, D'Souza DN, Goldstein DJ, Iyengar S, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005;119(1-3):5-15. (Pubitemid 41752960)
52. Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects. Prescrire Int 2006;15(85):168-72.
53. Penrod JR, Bernatsky S, Adam V, Baron M, Dayan N, Dobkin PL. Health services costs and their determinants in women with fibromyalgia. J Rheumatol 2004;31(7):1391-8. (Pubitemid 38879207)
54. Kivimaki M, Leino-Arjas P, Kaila-Kangas L, Virtanen M, Elovainio M, Puttonen S, et al. Increased absence due to sickness among employees with fibromyalgia. Ann Rheum Dis 2007;66(1):65-9. (Pubitemid 46044862)
55. Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ. Economic cost and epidemiological characteristics of patients with fibromyalgia claims. J Rheumatol 2003;30(6):1318-25. (Pubitemid 36666360)
56. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 1997; 40(9):1560-70. (Pubitemid 27426148)
57. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. Work and disability status of persons with fibromyalgia. J Rheumatol 1997;24(6):1171-8. (Pubitemid 27250128)
58. Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL, et al. Health status and disease severity in fibromyalgia: results of a six-center longitudinal study. Arthritis Rheum 1997;40(9):1571-9. (Pubitemid 27426149)
59. Boggio PS, Rigonatti SP, Ribeiro RB, Myczkowski ML, Nitsche MA, Pascual-Leone A, et al. A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression. Int J Neuropsychopharmacol 2008;11(2):249-54. (Pubitemid 351231819)
60. Boggio PS, Zaghi S, Lopes M, Fregni F. Modulatory effects of anodal transcranial direct current stimulation on perception and pain thresholds in healthy volunteers. Eur J Neurol 2008;15(10):1124-30.
61. Antal A, Brepohl N, Poreisz C, Boros K, Csifcsak G, Paulus W. Transcranial direct current stimulation over somatosensory cortex decreases experimentally induced acute pain perception. Clin J Pain 2008;24(1):56-63.
62. Fregni F, Boggio PS, Lima MC, Ferreira MJ, Wagner T, Rigonatti SP, et al. A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury. Pain 2006;122(1-2):197-209.
63. Banks S, andKerns, R. Explaining high rates of depression in chronic pain. A diathesis-stress framework. Psychol Bull 1996;(119):95-110.
64. Magni G, Marchetti, M., Roreschi, C., Merskey, H., Rigatti-Luchini, S. Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutritional Examination I: Epidemiologic follow-up study. Pain 1993;53:163-8. (Pubitemid 23161578)
65. Campbell LC, Clauw DJ, Keefe FJ. Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry 2003;54(3):399-409.
66. Dohrenwend BP, Raphael KG, Marbach JJ, Gallagher RM. Why is depression comorbid with chronic myofascial face pain? A family study test of alternative hypotheses. Pain 1999;83(2):183-92.
67. McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 2003;106(1-2):127-33.
68. Bornhovd K, Quante M, Glauche V, Bromm B, Weiller C, Buchel C. Painful stimuli evoke different stimulus-response functions in the amygdala, prefrontal, insula and somatosensory cortex: a single-trial fMRI study. Brain 2002;125(Pt 6):1326-36. (Pubitemid 34591096)
69. Brooks JC, Nurmikko TJ, Bimson WE, Singh KD, Roberts N. fMRI of thermal pain: effects of stimulus laterality and attention. Neuroimage 2002;15(2):293-301.
70. Davis KD. The neural circuitry of pain as explored with functional MRI. Neurol Res 2000;22(3):313-7.
71. Petrovic P, Ingvar M. Imaging cognitive modulation of pain processing. Pain 2002;95(1-2):1-5. (Pubitemid 34076771)
72. Sheline YI. Neuroimaging studies of mood disorder effects on the brain. Biol Psychiatry 2003;54(3):338-52.
73. Piccinni A, Del Debbio A, Medda P, Bianchi C, Roncaglia I, Veltri A, et al. Plasma Brain-Derived Neurotrophic Factor in treatment-resistant depressed patients receiving electroconvulsive therapy. Eur Neuropsychopharmacol 2009;13:13.
74. Okamoto T, Yoshimura R, Ikenouchi-Sugita A, Hori H, Umene-Nakano W, Inoue Y, et al. Efficacy of electroconvulsive therapy is associated with changing blood levels of homovanillic acid and brain-derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 2008;32(5):1185-90.
75. Hsieh JC, Belfrage M, Stone-Elander S, Hansson P, Ingvar M. Central representation of chronic ongoing neuropathic pain studied by positron emission tomography. Pain 1995;63(2):225-36.
76. Fukui S, Shigemori S, Nosaka S. Central pain associated with low thalamic blood flow treated by electroconvulsive therapy. J Anesth 2002;16(3):255-7.
77. Fukui S, Shigemori S, Yoshimura A, Nosaka S. Chronic pain with beneficial response to electroconvulsive therapy and regional cerebral blood flow changes assessed by single photon emission computed tomography. Reg Anesth Pain Med 2002;27(2):211-3. (Pubitemid 34258247)
78. Salmon JB, Hanna MH, Williams M, Toone B, Wheeler M. Thalamic pain--the effect of electroconvulsive therapy (ECT). Pain 1988; 33(1):67-71.
79. McCance S, Hawton K, Brighouse D, Glynn C. Does electroconvulsive therapy (ECT) have any role in the management of intractable thalamic pain? Pain 1996;68(1):129-31.
80. Huuhka MJ, Haanpaa ML, Leinonen EV. Electroconvulsive therapy in patients with depression and fibromyalgia. Eur J Pain 2004; 8(4):371-6.
81. Usui C, Doi N, Nishioka M, Komatsu H, Yamamoto R, Ohkubo T, et al. Electroconvulsive therapy improves severe pain associated with fibromyalgia. Pain 2006;121(3):276-80.
82. Takeuchi R, Yonekura Y, Matsuda H, Konishi J. Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET. Eur J Nucl Med Mol Imaging 2002; 29(3):331-41. (Pubitemid 34253244)
83. Vangu MD, Esser JD, Boyd IH, Berk M. Effects of electroconvulsive therapy on regional cerebral blood flow measured by 99mtechnetium HMPAO SPECT. Prog Neuropsychopharmacol Biol Psychiatry 2003;27(1):15-9. (Pubitemid 36126642)
84. Newman ME, Gur E, Shapira B, Lerer B. Neurochemical mechanisms of action of ECS: evidence from in vivo studies. J Ect 1998; 14(3):153-71. (Pubitemid 28433912)
85. Wasserman EA EC, Ziemann U, et al. The Oxford handbook of transcranial stimulation. New York: Oxford Univ Press, 2008.
86. Been G, Ngo TT, Miller SM, Fitzgerald PB. The use of tDCS and CVS as methods of non-invasive brain stimulation. Brain Res Rev 2007;56(2):346-61. (Pubitemid 350166527)
87. Nitsche M A PW. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol 2000; 527(3):633-9.
88. Nitsche MA, Fricke K, Henschke U, Schlitterlau A, Liebetanz D, Lang N, et al. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J Physiol 2003;553(Pt 1):293-301. (Pubitemid 37483935)
89. Nitsche MA, Seeber A, Frommann K, Klein CC, Rochford C, Nitsche MS, et al. Modulating parameters of excitability during and after transcranial direct current stimulation of the human motor cortex. J Physiol 2005;568(Pt 1):291-303. (Pubitemid 41448638)
90. Ghaly RF, Ham JH, Lee JJ. High-dose ketamine hydrochloride maintains somatosensory and magnetic motor evoked potentials in primates. Neurol Res 2001;23(8):881-6.
91. Ziemann U, Tergau F, Wischer S, Hildebrandt J, Paulus W. Pharmacological control of facilitatory I-wave interaction in the human motor cortex. A paired transcranial magnetic stimulation study. Electroencephalogr Clin Neurophysiol 1998;109(4):321-30.
92. Nitsche MA, Doemkes S, Karakose T, Antal A, Liebetanz D, Lang N, et al. Shaping the effects of transcranial direct current stimulation of the human motor cortex. J Neurophysiol 2007;97(4):3109-17. (Pubitemid 46557737)
93. Poreisz C, Boros K, Antal A, Paulus W. Safety aspects of transcranial direct current stimulation concerning healthy subjects and patients. Brain Res Bull 2007;72(4-6):208-14. (Pubitemid 46602748)
94. Schlaug G, Renga V, Nair D. Transcranial direct current stimulation in stroke recovery. Arch Neurol 2008;65(12):1571-6.
95. Fregni F, Gimenes R, Valle AC, Ferreira MJ, Rocha RR, Natalle L, et al. A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia. Arthritis Rheum 2006;54(12):3988-98. (Pubitemid 44955903)
96. Lefaucheur JP, Drouot X, Keravel Y, Nguyen JP. Pain relief induced by repetitive transcranial magnetic stimulation of precentral cortex. Neuroreport 2001;12(13):2963-5. (Pubitemid 32882016)
97. Fregni F, Boggio PS, Nitsche MA, Marcolin MA, Rigonatti SP, Pascual-Leone A. Treatment of major depression with transcranial direct current stimulation. Bipolar Disord 2006;8(2):203-4. (Pubitemid 44026775)
98. Doherty M, Smith J. Elusive 'alpha-delta' sleep in fibromyalgia and osteoarthritis. Ann Rheum Dis 1993;52(3):245.
99. Schneider-Helmert D, Whitehouse I, Kumar A, Lijzenga C. Insomnia and alpha sleep in chronic non-organic pain as compared to primary insomnia. Neuropsychobiology 2001;43(1):54-8. (Pubitemid 32041423)
100. Hauri P, Hawkins DR. Alpha-delta sleep. Electroencephalogr Clin Neurophysiol 1973;34(3):233-7.
101. Moldofsky H, Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 1976;38(1):35-44.
102. Older SA, Battafarano DF, Danning CL, Ward JA, Grady EP, Derman S, et al. The effects of delta wave sleep interruption on pain thresholds and fibromyalgia-like symptoms in healthy subjects; correlations with insulin-like growth factor I. J Rheumatol 1998;25(6):1180-6. (Pubitemid 28350895)
103. Lentz MJ, Landis CA, Rothermel J, Shaver JL. Effects of selective slow wave sleep disruption on musculoskeletal pain and fatigue in middle aged women. J Rheumatol 1999;26(7):1586-92. (Pubitemid 29317884)
104. Marshall L, Molle M, Hallschmid M, Born J. Transcranial direct current stimulation during sleep improves declarative memory. J Neurosci 2004;24(44):9985-92. (Pubitemid 39463580)
105. Roizenblatt S, Fregni F, Gimenez R, Wetzel T, Rigonatti SP, Tufik S, et al. Site-specific effects of transcranial direct current stimulation on sleep and pain in fibromyalgia: a randomized, sham-controlled study. Pain Pract 2007;7(4):297-306. (Pubitemid 350142298)
106. Eichhammer P, Kharraz A, Wiegand R, Langguth B, Frick U, Aigner JM, et al. Sleep deprivation in depression stabilizing antidepressant effects by repetitive transcranial magnetic stimulation. Life Sci 2002; 70(15):1741-9. (Pubitemid 34178360)
107. Hauri P, Chernik D, Hawkins D, Mendels J. Sleep of depressed patients in remission. Arch Gen Psychiatry 1974;31(3):386-91.
108. Tsubokawa T KY, Yamamoto T, et al.: (Wien). Chronic motor cortex stimulation for the treatment of central pain. Acta Neurochir Suppl 1991;52:137-9.
109. Bohning DE. Introduction and overview of TMS psysics. In: George MS, Belmaker RH, eds. Transcranial magnetic stimulation in neuropsychiatry. Washington, DC: Am Psychiatr Press, 2000:13-44.
110. George MS, Belmaker RH. Transcranial magnetic stimulation In: Meorge MS, Belmaker RH, eds. Neuropsychiatry, 1 ed. Washington, DC: Am Psychiatr Press, 2000.
111. George MS, Lisanby SH, Sackeim HA. Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiatry 1999;56(4):300-11.
112. Epstein CM, Meador KJ, Loring DW, Wright RJ, Weissman JD, Sheppard S, et al. Localization and characterization of speech arrest during transcranial magnetic stimulation. Clin Neurophysiol 1999;110(6):1073-9. (Pubitemid 29278899)
113. Amassian VE, Eberle L, Maccabee PJ, Cracco RQ. Modelling magnetic coil excitation of human cerebral cortex with a peripheral nerve immersed in a brain-shaped volume conductor: the significance of fiber bending in excitation. Electroencephalogr Clin Neurophysiol 1992;85(5):291-301.
114. Davey KR, Cheng CH, Epstein CM. Prediction of magnetically induced electric fields in biological tissue. IEEE Trans Biomed Eng 1991;38(5):418-22.
115. Nagarajan SS, Durand DM, Roth BJ, Wijesinghe RS. Magnetic stimulation of axons in a nerve bundle: effects of current redistribution in the bundle. Ann Biomed Eng 1995;23(2):116-26.
116. George MS, Nahas Z, Kozol FA, Li X, Yamanaka K, Mishory A, et al. Mechanisms and the current state of transcranial magnetic stimulation. CNS Spectr 2003;8(7):496-514.
117. Bear MF. Homosynaptic long-term depression: a mechanism for memory? Proc Natl Acad Sci U S A 1999;96(17):9457-8.
118. Stanton PK, Sejnowski TJ. Associative long-term depression in the hippocampus induced by hebbian covariance. Nature 1989; 339(6221):215-8.
119. Malenka RC, Nicoll RA. Long-term potentiation - a decade of progress? Science 1999;285(5435):1870-4.
120. Wang H, Wang X, Scheich H. LTD and LTP induced by transcranial magnetic stimulation in auditory cortex. Neuroreport 1996; 7(2):521-5. (Pubitemid 26105032)
121. Chen R, Classen J, Gerloff C, Celnik P, Wassermann EM, Hallett M, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997;48(5):1398-403. (Pubitemid 27240571)
122. Wu T, Sommer M, Tergau F, Paulus W. Lasting influence of repetitive transcranial magnetic stimulation on intracortical excitability in human subjects. Neurosci Lett 2000;287(1):37-40. (Pubitemid 30332372)
123. Cohrs S, Tergau F, Korn J, Becker W, Hajak G. Suprathreshold repetitive transcranial magnetic stimulation elevates thyroid-stimulating hormone in healthy male subjects. J Nerv Ment Dis 2001;189(6):393-7. (Pubitemid 32574855)
124. Desmurget M, Epstein CM, Turner RS, Prablanc C, Alexander GE, Grafton ST. Role of the posterior parietal cortex in updating reaching movements to a visual target. Nat Neurosci 1999;2(6):563-7. (Pubitemid 30491238)
125. Epstein CM, Verson R, Zangaladze A. Magnetic coil suppression of visual perception at an extracalcarine site. J Clin Neurophysiol 1996;13(3):247-52. (Pubitemid 26134192)
126. Flitman SS, Grafman J, Wassermann EM, Cooper V, O'Grady J, Pascual-Leone A, et al. Linguistic processing during repetitive transcranial magnetic stimulation. Neurology 1998;50(1):175-81. (Pubitemid 28106038)
127. George MS, Wassermann EM, Williams WA, Steppel J, Pascual-Leone A, Basser P, et al. Changes in mood and hormone levels after rapid-rate transcranial magnetic stimulation (rTMS) of the prefrontal cortex. J Neuropsychiatry Clin Neurosci 1996; 8(2):172-80. (Pubitemid 26138924)
128. Grafman J, Wassermann E. Transcranial magnetic stimulation can measure and modulate learning and memory. Neuropsychologia 1999;37(2):159-67. (Pubitemid 29062320)
129. Szuba MP, O'Reardon JP, Rai AS, Snyder-Kastenberg J, Amsterdam JD, Gettes DR, et al. Acute mood and thyroid stimulating hormone effects of transcranial magnetic stimulation in major depression. Biol Psychiatry 2001;50(1):22-7. (Pubitemid 32701990)
130. Lefaucheur JP, Drouot X, Menard-Lefaucheur I, Nguyen JP. Neuropathic pain controlled for more than a year by monthly sessions of repetitive transcranial magnetic stimulation of the motor cortex. Neurophysiol Clin 2004; 34(2):91-5. (Pubitemid 38586796)
131. Li X, Teneback CC, Nahas Z, Kozel FA, Large C, Cohn J, et al. Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology 2004;29(7):1395-407. (Pubitemid 38780663)
132. Paus T, Castro-Alamancos MA, Petrides M. Cortico-cortical connectivity of the human mid-dorsolateral frontal cortex and its modulation by repetitive transcranial magnetic stimulation. Eur J Neurosci 2001;14(8):1405-11. (Pubitemid 35463746)
133. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001; 21(15):RC157.
134. Teneback CC, Nahas Z, Speer AM, Molloy M, Stallings LE, Spicer KM, et al. Changes in prefrontal cortex and paralimbic activity in depression following two weeks of daily left prefrontal TMS. J Neuropsychiatry Clin Neurosci 1999;11(4):426-35.
135. George MS, Wassermann EM. Rapid-rate transcranial magnetic stimulation and ECT. Convuls Ther 1994;10(4):251-4,255-8.
136. Garcia-Larrea L, Peyron R, Mertens P, Gregoire MC, Lavenne F, Le Bars D, et al. Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study. Pain 1999; 83(2):259-73. (Pubitemid 29479285)
137. Peyron R, Kupers R, Jehl JL, Garcia-Larrea L, Convers P, Barral FG, et al. Central representation of the RIII flexion reflex associated with overt motor reaction: an fMRI study. Neurophysiol Clin 2007; 37(4):249-59. (Pubitemid 350051939)
138. Peyron R, Laurent B, Garcia-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis (2000). Neurophysiol Clin 2000;30(5):263-88.
139. Apkarian AV, Bushnell MC, Treede RD, Zubieta JK. Human brain mechanisms of pain perception and regulation in health and disease. Eur J Pain 2005;9(4):463-84.
140. Tracey I. Nociceptive processing in the human brain. Curr Opin Neurobiol 2005;15(4):478-87.
141. Bohning DE, Shastri A, McGavin L, McConnell KA, Nahas Z, Lorberbaum JP, et al. Motor cortex brain activity induced by 1-Hz transcranial magnetic stimulation is similar in location and level to that for volitional movement. Invest Radiol 2000;35(11):676-83.
142. Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J. Functional MRI of the immediate impact of transcranial magnetic stimulation on cortical and subcortical motor circuits. Eur J Neurosci 2004;19(7):1950-62. (Pubitemid 38482583)
143. Bestmann S, Baudewig J, Siebner HR, Rothwell JC, Frahm J. BOLD MRI responses to repetitive TMS over human dorsal premotor cortex. Neuroimage 2005;28(1):22-9. (Pubitemid 41393884)
144. Lefaucheur JP. New insights into the therapeutic potential of non-invasive transcranial cortical stimulation in chronic neuropathic pain. Pain 2006;122(1-2):11-3.
145. Lefaucheur JP, Drouot X, Menard-Lefaucheur I, Keravel Y, Nguyen JP. Motor cortex rTMS restores defective intracortical inhibition in chronic neuropathic pain. Neurology 2006;67(9):1568-74. (Pubitemid 44747925)
146. Kanda M, Mima T, Oga T, Matsuhashi M, Toma K, Hara H, et al. Transcranial magnetic stimulation (TMS) of the sensorimotor cortex and medial frontal cortex modifies human pain perception. Clin Neurophysiol 2003; 114(5):860-6. (Pubitemid 36556095)
147. Summers J, Johnson S, Pridmore S, Oberoi G. Changes to cold detection and pain thresholds following low and high frequency transcranial magnetic stimulation of the motor cortex. Neurosci Lett 2004;368(2):197-200. (Pubitemid 39194871)
148. Tamura Y, Okabe S, Ohnishi T, D NS, Arai N, Mochio S, et al. Effects of 1-Hz repetitive transcranial magnetic stimulation on acute pain induced by capsaicin. Pain 2004;107(1-2):107-15. (Pubitemid 38058705)
149. Johnson S, Summers J, Pridmore S. Changes to somatosensory detection and pain thresholds following high frequency repetitive TMS of the motor cortex in individuals suffering from chronic pain. Pain 2006;123(1-2):187-92. (Pubitemid 43816773)
150. Migita K, Uozumi T, Arita K, Monden S. Transcranial magnetic coil stimulation of motor cortex in patients with central pain. Neurosurgery 1995;36(5):1037-40.
151. Khedr EM, Kotb H, Kamel NF, Ahmed MA, Sadek R, Rothwell JC. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry 2005;76(6):833-8. (Pubitemid 40805815)
152. Sampson SM, Rome JD, Rummans TA. Slow-frequency rTMS reduces fibromyalgia pain. Pain Med 2006;7(2):115-8.
153. Passard AF, Attal N, Attal NF, Benadhira R, Benadhira RF, et al. Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia. Personal communication.
154. Graff-Guerrero A, Gonzalez-Olvera J, Fresan A, Gomez-Martin D, Mendez-Nunez JC, Pellicer F. Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain. Brain Res Cogn Brain Res 2005; 25(1):153-60. (Pubitemid 41282792)
155. Kauffmann CD, Cheema MA, Miller BE. Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study. Depress Anxiety 2004;19(1):59-62. (Pubitemid 38294610)
156. Peyron R, Garcia-Larrea L, Gregoire MC, Convers P, Richard A, Lavenne F, et al. Parietal and cingulate processes in central pain. A combined positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) study of an unusual case. Pain 2000;84(1):77-87.
157. Pridmore S, Oberoi G, Marcolin M, George M. Transcranial magnetic stimulation and chronic pain: current status. Australas Psychiatry. 2005;13(3):258-65. (Pubitemid 41800922)
158. Kakigi R, Inui K, Tamura Y. Electrophysiological studies on human pain perception. Clin Neurophysiol 2005;116(4):743-63. (Pubitemid 40431991)
159. Csifcsak G, Antal A, Hillers F, Levold M, Bachmann CG, Happe S, et al. Modulatory effects of transcranial direct current stimulation on laser-evoked potentials. Pain Med 2009;10(1):122-32.
160. Rigonatti SP, Boggio PS, Myczkowski ML, Otta E, Fiquer JT, Ribeiro RB, et al. Transcranial direct stimulation and fluoxetine for the treatment of depression. Eur Psychiatry 2008;23(1):74-6. (Pubitemid 351222740)
161. Gracely RH, Geisser ME, Giesecke T, Grant MA, Petzke F, Williams DA, et al. Pain catastrophizing and neural responses to pain among persons with fibromyalgia. Brain 2004;127(Pt 4):835-43. (Pubitemid 38478528)